Cell and Gene Therapies

Overview

The facility, launched by the Stanford Innovative Medicines Accelerator (IMA) and located in the Alexandria Center for Life Science at Stanford Research Park, helps bring potential novel medicines closer to patients by designing and producing high-quality AAV vectors and developing next-generation vectors to advance new medicines.